Having established that PIK3R1 loss activates STAT3 and AKT pathways in ovarian cancer cells, we reasoned that cells with PIK3R1 loss would be sensitive to inhibitors of these two pathways. This evidence concerns the gene PIK3R1 and ovarian carcinoma.